Literature DB >> 431033

Kinetics of elimination of thiocyanate in 7 healthy subjects and in 8 subjects with renal failure.

V Schulz, R Bonn, J Kindler.   

Abstract

The concentration of thiocyanate in the serum of eight test subjects with renal failure and seven healthy control subjects was measured, as it declined with time, after oral doses of thiocyanate or i.v. injections of nitroprusside had been administered. Additional measurements were taken, on the healthy subjects only, of the concentrations of thiocyanate in the urine, and also of the influence of an increased chloride intake on the rate of elimination of thiocyanate. For the healthy subjects an elimination half-life of between one and five days (mean c. 3 days) was found. Increasing the chloride elimination rate to approximately twice normal did not significantly speed up the rate of thiocyanate elimination. The amounts of thiocyanate which had been administered as doses reappeared almost exclusively in the urine. For the subjects with renal failure, the elimination half-life had a mean value of approximately nine days. The elimination constants were found to be proportional to the creatinine-clearance rates. The ke value at a creatinine-clearance of zero ml/min was approximately 15% of the ke value at a creatinine-clearance rate of 120 ml/min. The distribution volumes for thiocyanate were greater for the patients with renal failure than for the healthy subjects. The conclusions for therapies using nitroprusside are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 431033     DOI: 10.1007/bf01477493

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  8 in total

Review 1.  Drug therapy. Sodium nitroprusside.

Authors:  R F Palmer; K C Lasseter
Journal:  N Engl J Med       Date:  1975-02-06       Impact factor: 91.245

2.  NITRATE, THIOCYANATE, AND PERCHLORATE CLEARANCE IN RELATION TO CHLORIDE CLEARANCE.

Authors:  M WALSER; W J RAHILL
Journal:  Am J Physiol       Date:  1965-06

3.  Delirious reactions secondary to thiocyanate therapy of hypertension.

Authors:  C A DOMZALSKI; L C KOLB; E A HINES
Journal:  Proc Staff Meet Mayo Clin       Date:  1953-05-06

4.  Renal excretion of thiocyanate.

Authors:  M NICKERSON; J J THOMAS
Journal:  J Lab Clin Med       Date:  1951-08

5.  Permeability alterations in disease.

Authors:  R R OVERMAN
Journal:  J Lab Clin Med       Date:  1946-11

6.  The metabolism of thiocyanate after prolonged administration in man.

Authors:  F C MOISTER; E D FREIS
Journal:  Am J Med Sci       Date:  1949-11       Impact factor: 2.378

7.  Simultaneous distribution rate and dilution volume of bromide-82 and thiocyanate in body fluid overload: experimental and clinical correlation.

Authors:  C A Herbst
Journal:  Ann Surg       Date:  1974-02       Impact factor: 12.969

8.  [Thiocyanate intoxication with nitroprusside treatment for malignant hypertension (author's transl)].

Authors:  V Schulz; W Döhring; P Rathsack
Journal:  Klin Wochenschr       Date:  1978-04-01
  8 in total
  10 in total

Review 1.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

2.  [Thiocyanate intoxication with nitroprusside treatment for malignant hypertension (author's transl)].

Authors:  V Schulz; W Döhring; P Rathsack
Journal:  Klin Wochenschr       Date:  1978-04-01

3.  Counteraction of cyanide poisoning by thiosulphate when administering sodium nitroprusside as a hypotensive treatment.

Authors:  V Schulz; R Bonn; H Kämmerer; R Kriegel; N Ecker
Journal:  Klin Wochenschr       Date:  1979-09-03

4.  Cyanide toxicokinetics: the behavior of cyanide, thiocyanate and 2-amino-2-thiazoline-4-carboxylic acid in multiple animal models.

Authors:  Raj K Bhandari; Robert P Oda; Ilona Petrikovics; David E Thompson; Matthew Brenner; Sari B Mahon; Vikhyat S Bebarta; Gary A Rockwood; Brian A Logue
Journal:  J Anal Toxicol       Date:  2014-05       Impact factor: 3.367

Review 5.  Can we prevent or treat renal dysfunction in acute heart failure?

Authors:  Valentina Lazzarini; Luca Bettari; Silvia Bugatti; Valentina Carubelli; Carlo Lombardi; Marco Metra; Livio Dei Cas
Journal:  Heart Fail Rev       Date:  2012-03       Impact factor: 4.214

Review 6.  Clinical pharmacokinetics of nitroprusside, cyanide, thiosulphate and thiocyanate.

Authors:  V Schulz
Journal:  Clin Pharmacokinet       Date:  1984 May-Jun       Impact factor: 6.447

7.  Cyanide toxicity of sodium nitroprusside in therapeutic use with and without sodium thiosulphate.

Authors:  V Schulz; R Gross; T Pasch; J Busse; G Loeschcke
Journal:  Klin Wochenschr       Date:  1982-11-15

8.  Successful treatment by exchange transfusion of a young infant with sodium nitroprusside poisoning.

Authors:  Jong Geun Baek; Hoar Lim Jeong; Ji Sook Park; Ji Hyun Seo; Eun Sil Park; Jae Young Lim; Chan Hoo Park; Hyang Ok Woo; Hee Shang Youn; Jung Sook Yeom
Journal:  Korean J Pediatr       Date:  2010-08-31

9.  Pharmacological management of cardiorenal syndromes.

Authors:  Andrew A House; Mikko Haapio; Johan Lassus; Rinaldo Bellomo; Claudio Ronco
Journal:  Int J Nephrol       Date:  2011-05-26

10.  Temporal patterns in perchlorate, thiocyanate, and iodide excretion in human milk.

Authors:  Andrea B Kirk; Jason V Dyke; Clyde F Martin; Purnendu K Dasgupta
Journal:  Environ Health Perspect       Date:  2006-11-20       Impact factor: 9.031

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.